Compare SPOK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPOK | CDXS |
|---|---|---|
| Founded | 2004 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Major Chemicals |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.8M | 256.3M |
| IPO Year | 2004 | 2008 |
| Metric | SPOK | CDXS |
|---|---|---|
| Price | $10.65 | $1.42 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 146.7K | ★ 1.1M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | 2.74 | ★ 43.82 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $139,708,000.00 | $138,590,000.00 |
| Revenue This Year | $1.70 | $7.73 |
| Revenue Next Year | N/A | $14.24 |
| P/E Ratio | $36.76 | ★ N/A |
| Revenue Growth | 1.49 | ★ 32.30 |
| 52 Week Low | $9.95 | $0.96 |
| 52 Week High | $17.67 | $2.98 |
| Indicator | SPOK | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 36.97 |
| Support Level | $10.29 | $1.38 |
| Resistance Level | $10.85 | $1.76 |
| Average True Range (ATR) | 0.21 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 43.18 | 5.35 |
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.